Aug. 4 at 7:05 PM
$SOL.X You do not have enough 🔥🔥
New #Solana Treasury Company: Artelo Biosciences (Nasdaq: ARTL)Announces
$9.475 Million At-the-Market Private Placement to Initiate @solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt
$SOL as a Core Reserve Asset.
Lead investor Bartosz Lipiński, previously Head of Engineering at Solana Labs, will serve as a technical partner.
CUBE selected to secure storage, staking, and active DeFi execution of Artelo’s digital asset treasury.
Artelo’s Board approves authorization to expand Company’s SOL treasury management strategy over time.
sec.gov/Archives/edgar…